Profile
Sector:
Consumer DefensiveIndustry:
Household & Personal ProductsCountry:
United StatesIPO:
13 September 2019Website:
http://www.forhims.comNext earnings report:
04 November 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | 9 min agoDividend
Analysts recommendations
Institutional Ownership
HIMS Latest News
We don't expect any sudden movements in the stock market until Wednesday morning the earliest.
Disrupting pharmacies is just the start for Hims & Hers.
Hims & Hers Health (HIMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GLP-1s get all the attention, but Hims & Hers' core business is where the rocket growth is.
Hims & Hers is revolutionizing healthcare with affordable, convenient telehealth services, leading to a 260% stock increase in the last year. The company benefits from GLP-1 drug sales and is positioned for high margins and recurring revenues in the growing healthcare market. HIMS achieved positive operating income with 50% revenue growth and 270% EBITDA increase, signaling strong financial health and future potential.
Hims & Hers Health (HIMS) shares surged Monday after the Food and Drug Administration (FDA) said compounding pharmacies could continue to produce copycat weight-loss drugs while it reconsiders whether there is a shortage of their active ingredient.
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced that it will report third quarter financial results after the market closes on Monday, November 4, 2024. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referenci.
Shares of Hims & Hers Health Inc (NYSE:HIMS) are popping 10% higher to trade at $20.50 this morning, running higher off good news from the Food and Drug Administration (FDA).
Is Hims & Hers in trouble since the FDA put a time clock on some GLP-1s, or is the future still bright?
Look beyond the stock price at the business when shares are volatile.
What type of business is Hims & Hers Health?
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
What sector is Hims & Hers Health in?
Hims & Hers Health is in the Consumer Defensive sector
What industry is Hims & Hers Health in?
Hims & Hers Health is in the Household & Personal Products industry
What country is Hims & Hers Health from?
Hims & Hers Health is headquartered in United States
When did Hims & Hers Health go public?
Hims & Hers Health initial public offering (IPO) was on 13 September 2019
What is Hims & Hers Health website?
https://www.forhims.com
Is Hims & Hers Health in the S&P 500?
No, Hims & Hers Health is not included in the S&P 500 index
Is Hims & Hers Health in the NASDAQ 100?
No, Hims & Hers Health is not included in the NASDAQ 100 index
Is Hims & Hers Health in the Dow Jones?
No, Hims & Hers Health is not included in the Dow Jones index
When was Hims & Hers Health the previous earnings report?
No data
When does Hims & Hers Health earnings report?
The next expected earnings date for Hims & Hers Health is 04 November 2024